Abstract
GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico — Insufficienza cardiaca) provides support for the use of fish oil supplements in patients with symptomatic heart failure but indicates no benefit of statin therapy in this patient population. Fish oil supplements reduced the risk of all-cause death or hospitalization for cardiovascular causes, while treatment with rosuvastatin had no effect on these outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
